Search
for
Sort by
Research 271–300 of 1000+
- Effect of Fenugreek Extract on Testosterone Propionate-Induced Benign Prostatic Hyperplasia
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- Current treatment of BPH
- Diseases of the Canine Prostate Gland
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
- Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia
- Hormonal manipulation of benign prostatic hyperplasia
- Effect of Saw Palmetto Supplements on Androgen-Sensitive LNCaP Human Prostate Cancer Cell Number and Syrian Hamster Flank Organ Growth
- Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments
- Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis
- Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis
- EFFECT OF A COMBINATION OF DUTASTERIDE AND PARENTERAL TESTOSTERONE UNDECANOATE ON TESTOSTERONE DEFICIENCY SYMPTOMS AND PROSTATE IN PATIENTS WITH TESTOSTERONE DEFICIENCY AND BENIGN PROSTATIC HYPERPLASIA
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer
- mRNA Levels of Aromatase, 5α-Reductase Isozymes, and Prostate Cancer-Related Genes in Plucked Hair from Young Men with Androgenic Alopecia
- Re: Association of Treatment with 5α-Reductase Inhibitors with Time to Diagnosis and Mortality in Prostate Cancer
- Distinct Developmental Functions of Prostasin (CAP1/PRSS8) Zymogen and Activated Prostasin
- Direct cellular reprogramming enables development of viral T antigen–driven Merkel cell carcinoma in mice
- 5‐α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population‐based cohort study
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Endocrinology of the Aging Prostate: Current Concepts
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Effect of dose reduction of dutasteride in combination with alpha-blockers in patients with lower urinary tract symptoms/benign prostatic enlargement
- Referee report. For: Exploring the use of phytotherapy in benign prostatic hyperplasia [BPH]: a systematic review [version 1; peer review: 2 approved with reservations]
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
- A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia